Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Apple: Rekord nach Rekord – weil "techy"!
Apple: Rekord nach Rekord – weil "techy"!

Es hat ein Mega-Run auf die großen US-Tech-Aktien eingesetzt, einer der großen Profiteure ist Apple (WKN: 865985). Nach dem 4-zu-1 Split handeln Apple-Aktien heute bereits adjustiert – und steigen

Microsoft: Erste Wolken am Himmel?
Microsoft: Erste Wolken am Himmel?

Gestern Abend, nachbörslich, legte auch Microsoft (WKN: 870747) seine aktuellen Geschäftszahlen für das zweite Quartal vor. Obwohl diese besser als erwartet ausfielen, geriet die Aktie im Nachgang

Nike: Darum hagelt es heute Kaufempfehlungen!
Nike: Darum hagelt es heute Kaufempfehlungen!

Der größte Sportartikelhersteller der Welt, die US-amerikanische Nike (WKN: 866993), hat gestern Abend – nachbörslich – seine aktuellen Quartalszahlen vorgelegt. Obwohl Analysten und Anleger

Walt Disney: Grusel-Zahlen, aber...
Walt Disney: Grusel-Zahlen, aber...

Walt Disney (WKN: 855686) berichtet für das zweite Quartal von Januar bis März einen Gewinneinbruch von 5,4 Milliarden US-Dollar auf 460 Millionen US-Dollar. Im Themenpark-Segment, das gut ein

Pfizer Reports Strong Second-Quarter 2024 Results And Raises 2024 Guidancehttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Reports Strong Second-Quarter 2024 Results And Raises 2024 Guidance


Pfizer Inc. (NYSE: PFE) reported financial results for the second quarter of 2024 and raised its full-year 2024 guidance(1) for both Revenues and Adjusted(2) diluted EPS.



The second-quarter 2024

European Commission Approves Pfizer’s DURVEQTIX® (fidanacogene elaparvovec), a One-Time Gene Therapy for Adults with Hemophilia Bhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
European Commission Approves Pfizer’s DURVEQTIX® (fidanacogene elaparvovec), a One-Time Gene Therapy for Adults with Hemophilia B


Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted conditional marketing authorization for DURVEQTIX® (fidanacogene elaparvovec), a gene therapy for the treatment

Pfizer Announces Positive Topline Results From Phase 3 Study of Hemophilia A Gene Therapy Candidatehttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Announces Positive Topline Results From Phase 3 Study of Hemophilia A Gene Therapy Candidate


Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 AFFINE study (NCT04370054) evaluating giroctocogene fitelparvovec, an investigational gene therapy for the

ExxonMobil to Release Second Quarter 2024 Financial Resultshttp://upload.wikimedia.org/wikipedia/commons/1/18/Exxon_Mobil_Logo.svg: By KUsam at en.wikipedia. Later version(s) were uploaded by Cheeselouise at en.wikipedia. [Public domain], from Wikimedia Commons
ExxonMobil to Release Second Quarter 2024 Financial Results


Exxon Mobil Corporation (NYSE: XOM) will release its second quarter 2024 financial results on Friday, August 2, 2024. The company will issue a press release via Business Wire that will be available

American Express Raises Full-Year Earnings Per Share Guidancehttp://upload.wikimedia.org/wikipedia/commons/3/30/American_Express_logo.svg: By CoolKid1993 at en.wikipedia. Later version(s) were uploaded by Tkgd2007 at en.wikipedia. [Public domain], from Wikimedia Commons
American Express Raises Full-Year Earnings Per Share Guidance


American Express Company (NYSE: AXP) today reported second-quarter net income of $3.0 billion, or $4.15 per share, compared with net income of $2.2 billion, or $2.89 per share, a year ago

Calvert Impact Announces National Program to Capitalize Small Businesses: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23885/Goldman_Sachs.svg.png
Calvert Impact Announces National Program to Capitalize Small Businesses


Calvert Impact today announced the launch of Access by Calvert Impact, a national public-private partnership to support small businesses, with the closing of an $140 million warehouse credit

Pfizer Advances Development of Once-Daily Formulation of Oral GLP-1 Receptor Agonist Danuglipronhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Advances Development of Once-Daily Formulation of Oral GLP-1 Receptor Agonist Danuglipron


Pfizer Inc. (NYSE: PFE) today announced that based on results from the ongoing pharmacokinetic study (NCT06153758), the company has selected its preferred once-daily modified release formulation

Pfizer to Launch Process to Identify a Successor for Dr. Mikael Dolsten, Chief Scientific Officer and President, Pfizer Research & Developmenthttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer to Launch Process to Identify a Successor for Dr. Mikael Dolsten, Chief Scientific Officer and President, Pfizer Research & Development


Pfizer Inc. (NYSE: PFE) today announced that the company is launching the process to identify a successor for Dr. Mikael Dolsten, Pfizer’s Chief Scientific Officer and President, Pfizer Research &amp

American Express Declares Dividend on Series D Preferred Stockhttp://upload.wikimedia.org/wikipedia/commons/3/30/American_Express_logo.svg: By CoolKid1993 at en.wikipedia. Later version(s) were uploaded by Tkgd2007 at en.wikipedia. [Public domain], from Wikimedia Commons
American Express Declares Dividend on Series D Preferred Stock


The Board of Directors of American Express Company (NYSE: AXP) has declared a quarterly dividend on the Company’s 3.550% Fixed Rate Reset Noncumulative Preferred Shares, Series D, of $9,072.22 per

Advisory: Chevron Corporation’s 2Q 2024 Earnings Conference Call and Webcasthttp://intelligents.wpengine.netdna-cdn.com/wp-content/uploads/2011/04/chevron-corporation-logo.png: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/11090/chevron-corporation-logo.png
Advisory: Chevron Corporation’s 2Q 2024 Earnings Conference Call and Webcast


Chevron Corporation (NYSE: CVX), one of the world’s leading energy companies, will hold its quarterly earnings conference call on Friday, August 2, 2024, at 11:00 a.m. ET (8:00 a.m. PT).

Cyrus Taraporevala Elected to Pfizer’s Board of Directorshttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Cyrus Taraporevala Elected to Pfizer’s Board of Directors


Pfizer Inc. (NYSE: PFE) today announced the election of Cyrus Taraporevala to its Board of Directors, effective immediately. Mr. Taraporevala, age 57, was also appointed to and will join the Audit

NIKE, Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Results:
NIKE, Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Results


NIKE, Inc. (NYSE:NKE) today reported financial results for its fiscal 2024 fourth quarter and full year ended May 31, 2024.




  • Full year revenues were $51.4 billion compared to $51.2 billion in

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Unionhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union


Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)

Pfizer Declares Third-Quarter 2024 Dividendhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Declares Third-Quarter 2024 Dividend


Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 third-quarter 2024 dividend on the company’s common stock, payable September 3, 2024, to holders of the Common

ExxonMobil and EV battery maker SK On sign MOU regarding U.S. produced Mobil™ Lithiumhttp://upload.wikimedia.org/wikipedia/commons/1/18/Exxon_Mobil_Logo.svg: By KUsam at en.wikipedia. Later version(s) were uploaded by Cheeselouise at en.wikipedia. [Public domain], from Wikimedia Commons
ExxonMobil and EV battery maker SK On sign MOU regarding U.S. produced Mobil™ Lithium


ExxonMobil (NYSE: XOM) has signed a non-binding memorandum of understanding (MOU) with SK On, a global leading electric vehicle (EV) battery developer, that opens the door to secure a multiyear

ExxonMobil Adds Air Liquide to World’s Largest Low-Carbon Hydrogen Projecthttp://upload.wikimedia.org/wikipedia/commons/1/18/Exxon_Mobil_Logo.svg: By KUsam at en.wikipedia. Later version(s) were uploaded by Cheeselouise at en.wikipedia. [Public domain], from Wikimedia Commons
ExxonMobil Adds Air Liquide to World’s Largest Low-Carbon Hydrogen Project


ExxonMobil (NYSE: XOM) and Air Liquide today announced an agreement to support the production of low-carbon hydrogen and low-carbon ammonia at ExxonMobil’s Baytown, Texas facility. The agreement

American Express Plans Live Audio Webcast of Second Quarter 2024 Earnings Conference Callhttp://upload.wikimedia.org/wikipedia/commons/3/30/American_Express_logo.svg: By CoolKid1993 at en.wikipedia. Later version(s) were uploaded by Tkgd2007 at en.wikipedia. [Public domain], from Wikimedia Commons
American Express Plans Live Audio Webcast of Second Quarter 2024 Earnings Conference Call


American Express Company (NYSE: AXP) plans to host a live audio webcast of its earnings conference call at 8:30 a.m. (ET) on Friday, July 19, 2024, to discuss second-quarter 2024 financial results

Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analystshttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts


Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:30 a.m. EDT on Tuesday, July 30, 2024. The

ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myelomahttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma


Pfizer Inc. (NYSE: PFE) today announced detailed overall survival (OS) results from the Phase 2 MagnetisMM-3 study of ELREXFIO™ (elranatamab-bcmm) in patients with heavily pretreated relapsed or

Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular Dystrophyhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular Dystrophy


Pfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin gene therapy

Walmart Leadership to Participate in Upcoming Investor Eventshttp://upload.wikimedia.org/wikipedia/commons/3/3d/Wal-Mart_logo.svg: By Wal-Mart Stores, Inc. [Public domain], via Wikimedia Commons
Walmart Leadership to Participate in Upcoming Investor Events


Walmart Inc. (NYSE: WMT) announced today that company leadership will participate in upcoming investor events. Links to those with live webcasts can be found on Walmart’s investor relations website